Orthobond Corporation
Treating and Protecting the Surfaces of the World
Treating and Protecting the Surfaces of the World
Orthobond Corporation is an antimicrobial technology company that has developed proprietary antimicrobial nanosurfaces, with broad applications in the medical device industry and more such as commercial, industrial, automotive, and beyond. Founded in 2004 in the United States, Orthobond is the first company to utilize nanoscale surface modifications that can be permanently bound to any surface, killing bacteria, viruses, and fungi by mechanically rupturing pathogens without using antibiotics.
The company recently received a $2.15M Series A investment on 21 October 2011. Orthobond's innovative technology and its potential to revolutionize multiple industries make it an attractive venture capital opportunity in the Biotechnology and Health Care sectors. With a strong focus on treating and protecting various surfaces, Orthobond is poised for significant growth and impact.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $2.15M | - | 21 Oct 2011 |
No recent news or press coverage available for Orthobond Corporation.
We care about your data, and we'd love to use cookies make your experience better.